EFFECTIVE USE OF MONOCLONAL ANTIBODIES AGAINST TNF — ADALIMUMAB — AS A SWITCHOVER DRUG IN A PATIENT WITH JUVENILE IDIOPATHIC POLYARTHRITIS AND UVEITIS

EFFECTIVE USE OF MONOCLONAL ANTIBODIES AGAINST TNF — ADALIMUMAB — AS A SWITCHOVER DRUG IN A PATIENT WITH JUVENILE IDIOPATHIC POLYARTHRITIS AND UVEITIS

The article presents a case of severe juvenile idiopathic arthritis associated uveitis in a patient who contracted the disease at the age of 10 year. Uveitis developed 9 months after manifestation of the articular syndrome in the event of etanercept therapy. Switch to adalimumab induced remission of...

Full description

Saved in:
Bibliographic Details
Main Authors: S. A. Ushakova, N. L. Ashcheulova, L. N. Koneva, O. Yu. Khalidullina, O. V. Pavlova, V. S. Rezenova, V. N. Luk'yanova, E. E. Fedorova, M. V. Pshenichkova
Format: Article
Language:Russian
Published: Union of pediatricians of Russia 2014-11-01
Series:Педиатрическая фармакология
Subjects:
juvenile idiopathic arthritis
uveitis
treatment
adalimumab
Online Access:https://www.pedpharma.ru/jour/article/view/38
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.pedpharma.ru/jour/article/view/38

Similar Items